All In MedTech

Device Trial Radar · NCT07633171

Multimodal Glucose Prediction in Type 2 Diabetes

CGM- and Behavior-based Large Health Model for Just-in-time Diabetes Management

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

36

Planned (sponsor's estimate)

Start

Oct 7, 2026

Primary completion

Jan 15, 2027

Study completion Feb 26, 2027

Sponsor

Lead sponsor
Johns Hopkins UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Samsung Research America; Welldoc
First posted
Jun 8, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that integrate Continuous Glucose Monitoring (CGM) data with patient behavior data (food intake, medication, and physical activity) to improve real-time glucose prediction and personalized diabetes management for patients with Type 2 diabetes (T2D), delivered via mobile apps and digital health tools.

Conditions

  • Type 2 Diabetes

Interventions

  • Digital Health Data Collection SystemDevice

    Participants will use a digital health data collection system that includes the Welldoc app, a Samsung smartwatch, and the participant's existing continuous glucose monitor. The system will collect CGM data, smartwatch-derived activity, sleep, and vital sign data, and app-based behavioral information such as meals, physical activity, and medication use. Participants will continue usual diabetes care and will not receive treatment recommendations from the study team. Data will be used to develop and validate glucose prediction models and Artificial Intelligence (AI)-generated research outputs that will be reviewed by the study team and not delivered to participants.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Root Mean Square Error of CGM Glucose Prediction ModelTime frame: Up to 3 Month follow-up

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Johns Hopkins Medicine

    Baltimore, Maryland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.